XJ-MK-002

N/A

Report date: 2026/03/16 11:25:54
First In Class

Base Information

Drug NameXJ-MK-002
Drug Alias NameUmbilical Cord Blood Megakaryocyte cell therapy (Xueji Biotechnology)XJ-MK-002XJ-002
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsThrombocytopeniaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Xueji Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCancer Hospital Of Chinese Academy Of Medical SciencesSuzhou Xueji Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombocytopeniaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A